QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

GLSI

QT59Greenwich LifeSciences, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
23.38
-0.61-2.54%
OverviewShort InterestFilings
GLSIQT59Greenwich LifeSciences, Inc.·NASDAQ
OverviewShort InterestFilings
23.38-2.54%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own-
Shs Outstand14.68M
Perf Week1.52%
Market Cap352.13MForward P/E-EPS next Y-1.47Insider Trans0.08%Shs Float-Perf Month-11.14%
Enterprise Value341.62MPEG0.75EPS next Q-0.34Inst Own-Short Float-Perf Quarter-9.66%
Income-21937712.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y124.81%
Sales-P/B66.30EPS next Y-8.89%ROA-207.10%Short Interest-Perf YTD11.28%
Book/sh0.14P/C-EPS next 5Y-ROE-814.48%52W High34.10 -31.44%Perf Year158.91%
Cash/sh-0.48P/FCF-EPS past 3/5Y-ROIC-415.38%52W Low7.78 200.51%Perf 3Y-
Dividend Est.-EV/EBITDA-15.70Sales past 3/5Y-Gross Margin0.00%Volatility5.01% 6.06%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-2.48%Oper. Margin0.00%ATR (14)2.04Perf 10Y-
Dividend Ex-Date-Quick Ratio2.01Sales Y/Y TTM-Profit Margin0.00%RSI (14)45.66Recom2.00
Dividend Gr. 3/5Y-Current Ratio2.01EPS Q/Q-95.00%SMA20-5.99%Beta2.80Target Price50.00
Payout0.00%Debt/Eq0.00Sales Q/Q-SMA50-5.79%Rel Volume0.65Prev Close23.99
Employees4LT Debt/Eq-EarningsAug 13SMA20021.73%Avg Volume137.43KPrice23.38
IPO DateSep 25, 2020Option/ShortYes / YesEPS/Sales Surpr.-18.18% -Net Debt/EBITDA0.48Volume89,788Change-2.54%
Analyst Ratings
DateActionAnalystRatingTarget
Dec-30-25ReiteratedH.C. Wainwright$39 → $50
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
FY 2017
12/31/2017
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A
000
Gross Profit
000
Selling, General and Administrative Excl. Other222
Research and Development17158
Other Operating Expense01-1
Operating Income-19-18-9
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)
000
Net Income Before Taxes-19-17-9
Income Taxes
000
Consolidated Net Income-19-17-9
Net Income From Continuing Operations-19-17-9
Net Income-19-17-9
EPS (Recurring)-1.43-1.21-0.69
EPS (Basic, Before Extraordinaries)-1.43-1.21-0.69
EPS (Diluted)-1.43-1.21-0.69
EBITDA-19-17-9
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding141313
Market Capitalization294——
Operating Lease Expense
———
Insider Trading Volume
$28.66$27.01$25.35$23.69$22.04● Close Price0.00K51.65K103.30K154.96K206.61KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Patel SnehalCEO and CFOJan 13 '26Buy29.831,80053,6945,604,102Jan 15 12:00 AM
Patel SnehalCEO and CFOJan 12 '26Buy27.542,90079,8665,602,302Jan 14 12:00 AM
Patel SnehalCEO and CFODec 31 '25Buy21.364,30091,8485,599,402Jan 05 12:00 AM
Patel SnehalCEO and CFODec 30 '25Buy21.732,90063,0175,595,102Jan 02 12:00 AM
Patel SnehalCEO and CFODec 18 '25Buy12.624,10051,7425,592,202Dec 19 12:00 AM
Patel SnehalCEO and CFONov 25 '25Buy8.374,60038,5025,588,102Nov 28 12:00 AM
Patel SnehalCEO and CFONov 07 '25Buy8.4310,60089,3585,583,502Nov 12 12:00 AM
Patel SnehalCEO and CFOOct 31 '25Buy9.262,30021,2985,572,902Nov 04 12:00 AM
Patel SnehalCEO and CFOApr 25 '25Buy9.883,60035,5685,570,602Apr 29 12:00 AM
Patel SnehalCEO and CFOApr 17 '25Buy8.985,40048,4925,567,002Apr 22 12:00 AM
Patel SnehalCEO and CFOApr 07 '25Buy9.103,60032,7605,561,602Apr 08 12:00 AM
Patel SnehalCEO and CFOApr 04 '25Buy8.735,50048,0155,558,002Apr 07 12:00 AM
Patel SnehalCEO and CFOJan 10 '25Buy12.512,50031,2755,552,502Jan 13 12:00 AM
Patel SnehalCEO and CFOJan 07 '25Buy13.751,80024,7505,550,002Jan 08 12:00 AM
Patel SnehalCEO and CFOJan 06 '25Buy13.311,10014,6415,548,202Jan 08 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR